title: Fibroblast growth factor signaling deficiencies impact female reproduction and kisspeptin neurons in mice.
abstract: Fibroblast growth factor (FGF) signaling is essential for the development of the gonadotropin-releasing hormone (GnRH) system. Mice harboring deficiencies in Fgf8 or Fgf receptor 1 (Fgfr1) suffer a significant loss of GnRH neurons, but their reproductive phenotypes have not been examined. This study examined if female mice hypomorphic for Fgf8, Fgfr1, or both (compound hypomorphs) exhibited altered parameters of pubertal onset, estrous cyclicity, and fertility. Further, we examined the number of kisspeptin (KP)-immunoreactive (ir) neurons in the anteroventral periventricular/periventricular nuclei (AVPV/PeV) of these mice to assess if changes in the KP system, which stimulates the GnRH system, could contribute to the reproductive phenotypes. Single hypomorphs (Fgfr1(+/-) or Fgf8(+/-)) had normal timing for vaginal opening (VO) but delayed first estrus. However, after achieving the first estrus, they underwent normal expression of estrous cycles. In contrast, the compound hypomorphs underwent early VO and normal first estrus, but had disorganized estrous cycles that subsequently reduced their fertility. KP immunohistochemistry on Postnatal Day 15, 30, and 60 transgenic female mice revealed that female compound hypomorphs had significantly more KP-ir neurons in the AVPV/PeV compared to their wild-type littermates, suggesting increased KP-ir neurons may drive early VO but could not maintain the cyclic changes in GnRH neuronal activity required for female fertility. Overall, these data suggest that Fgf signaling deficiencies differentially alter the parameters of female pubertal onset and cyclicity. Further, these deficiencies led to changes in the AVPV/PeV KP-ir neurons that may have contributed to the accelerated VO in the compound hypomorphs.
authors.affiliation: Department of Integrative Physiology and Center for Neuroscience, University of Colorado, Boulder, Colorado, USA. brooke.tata@etu.univ-paris-diderot.fr
authors.forename: Brooke K
authors.initials: BK
authors.lastname: Tata
authors.forename: Wilson C J
authors.initials: WC
authors.lastname: Chung
authors.forename: Leah R
authors.initials: LR
authors.lastname: Brooks
authors.forename: Scott I
authors.initials: SI
authors.lastname: Kavanaugh
authors.forename: Pei-San
authors.initials: PS
authors.lastname: Tsai
mesh_terms: D000818:Animals; D020643:Anterior Thalamic Nuclei / Q000378:metabolism; D002450:Cell Communication / Q000502:physiology; D030762:Estrous Cycle / Q000378:metabolism; D005260:Female; D051524:Fibroblast Growth Factor 8 / Q000235:genetics / Q000378:metabolism*; D007987:Gonadotropin-Releasing Hormone / Q000378:metabolism; D007247:Infertility, Female / Q000378:metabolism*; D059648:Kisspeptins / Q000378:metabolism*; D051379:Mice; D008822:Mice, Transgenic; D020644:Midline Thalamic Nuclei / Q000378:metabolism; D009474:Neurons / Q000378:metabolism; D051496:Receptor, Fibroblast Growth Factor, Type 1 / Q000235:genetics / Q000378:metabolism*; D012098:Reproduction / Q000502:physiology*; D012741:Sexual Maturation / Q000502:physiology; D015398:Signal Transduction / Q000502:physiology
chemical_list: C496457:Fgf8 protein, mouse; D059648:Kisspeptins; D051524:Fibroblast Growth Factor 8; D007987:Gonadotropin-Releasing Hormone; C496349:Fgfr1 protein, mouse; D051496:Receptor, Fibroblast Growth Factor, Type 1